Your doctor prescribed testosterone for menopause. So why won’t the pharmacy fill it?

Have you ever been prescribed a medication off label and been surprised to learn that the product was never actually designed for people like you?

Testosterone has become one of the hottest topics in menopause care. Prescriptions for women are rising rapidly, social media is filled with claims about libido, energy and muscle, and the FDA recently held a public workshop devoted entirely to testosterone use in menopausal women.

But women who receive a prescription can run into an unexpected problem: the pharmacy may not fill it.

The reason is not that testosterone can never be prescribed to women. Doctors may legally prescribe an approved drug “off label” when they believe it is medically appropriate. The bigger problem is that there is still no FDA-approved testosterone product formulated specifically for women in the United States, so clinicians often have to adapt products designed and dosed for men.

Prescriptions have surged

A healthcare-data analysis reported by Reuters found that the rate of women receiving testosterone prescriptions increased 146% from January 2023 through July 2026. That is a striking increase in just a few years.

The rise comes amid broader interest in menopause treatment and intense online discussion of testosterone. Yet the evidence is much narrower than many social-media claims suggest.

Current professional guidance supports systemic testosterone primarily for appropriately selected postmenopausal women with hypoactive sexual desire disorder, or HSDD—persistently low sexual desire that causes personal distress. Evidence is not currently strong enough to recommend testosterone as a general treatment for fatigue, brain fog, mood, muscle loss or overall “wellness.”

Why pharmacies can balk

Because products sold in the United States are formulated for men, women may be prescribed a very small fraction of a standard male dose. That can require carefully measuring a portion of a gel packet or using another dosing workaround.

Reuters reported that some clinicians and patients have encountered delays or denials at pharmacies, including policies against dispensing prescriptions that require patients to customize doses from male formulations.

A pharmacy rejection does not necessarily mean the prescription is medically inappropriate. It may reflect dispensing, dosing or safety policies created around products that were never designed for female dosing.

READ: Hormone therapy isn’t a general treatment for depression — but a new menopause study found intriguing mood changes

The FDA agrees there is a gap

At its September 17 workshop, the FDA acknowledged both growing off-label use and major knowledge gaps. The agency highlighted unanswered questions involving sexual function, cognition, mood, musculoskeletal health, testosterone measurement and long-term cardiovascular and breast-cancer safety.

FDA officials encouraged manufacturers to generate data that could support future approval of products specifically designed for women.

That would matter for more than convenience. A female-specific product could provide standardized dosing and prescribing information rather than forcing clinicians to adapt medications manufactured at much higher male doses.

Compounded testosterone is another option—but not the same thing

When standard prescriptions are difficult to dose or obtain, some women turn to compounded testosterone creams or other preparations.

Compounding can serve legitimate needs when an FDA-approved product cannot meet a patient’s requirements. But compounded medications do not undergo the same FDA premarket review for effectiveness, dosing consistency and manufacturing quality as approved products.

“Compounded,” “custom” and “bioidentical” should not automatically be interpreted as safer or better. Women considering compounded testosterone should understand why it is being recommended and how the dose will be monitored.

More testosterone is not better

Women naturally produce testosterone, but normal female concentrations are far below typical male levels. Treatment aims to keep testosterone within a physiologic female range rather than create male-range levels.

Excess exposure can cause acne, increased facial or body hair and scalp hair thinning. Higher doses can also produce voice deepening and clitoral enlargement, changes that may not fully reverse.

That is one reason careful dosing and follow-up matter—especially when a woman is using a product originally manufactured for men.

A blood level cannot diagnose low desire

Testing can help establish a baseline and monitor treatment, but there is no single testosterone number that proves a woman has HSDD or explains why her libido has changed.

Low desire can be influenced by vaginal pain or dryness, medications, depression, anxiety, sleep problems, relationship factors, chronic illness, stress and other hormonal changes.

A prescription should begin with the symptom being treated, not simply with a laboratory value labeled “low.”

Questions to ask before filling a prescription

_SetsukoN from Getty Images Signature via Canva

If testosterone is recommended, ask what symptom it is intended to treat, what evidence supports that use, what formulation you are receiving and how the dose compares with doses studied in women. Ask how testosterone levels and side effects will be monitored and how long you should try treatment before deciding whether it is helping.

If a pharmacy refuses to fill the prescription, contact the prescriber rather than improvising a different dose or buying an unverified product online. The clinician may be able to clarify the prescription, use a different formulation or identify a pharmacy comfortable dispensing the prescribed regimen.

Final word

The surge in testosterone prescribing exposes an unusual gap in American medicine: a hormone with evidence for a specific problem in some postmenopausal women is being prescribed more frequently, yet women still do not have an FDA-approved product designed for them.

That gap helps explain both the pharmacy problems and the growing call for better research.

For now, women should be wary of two extremes: the claim that testosterone has no legitimate role in menopause care and the equally unsupported claim that it is a universal fix for energy, cognition, muscle and aging.

QUESTION FOR READERS: Have you ever been prescribed a medication off label and been surprised to learn that the product was never actually designed for people like you?